安徽中环环保科技股份有限公司（以下简称"公司"）于 2025 年 4 月 18 日 召开第四届董事会第六次会议，审议通过了《关于择期召开公司 2024 年年度股 东大会的议案》。公司董事会经过认真审议，决定择期召开 2024 年年度股东大 会，具体的会议召开时间、地点、议案内容等信息将以另行公告的股东大会通知 为准。 特此公告。 安徽中环环保科技股份有限公司董事会 2025 年 4 月 22 日 | 证券代码:300692 | 证券简称:中环环保 | 公告编号:2025-025 | | --- | --- | --- | | 债券代码:123146 | 债券简称:中环转 2 | | 安徽中环环保科技股份有限公司 关于择期召开 2024 年年度股东大会的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 ...

债券代码:123146 债券简称:中环转 2 证券代码:300692 证券简称:中环环保 公告编号:2025-009 安徽中环环保科技股份有限公司 第四届监事会第四次会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 安徽中环环保科技股份有限公司（以下简称"公司"）第四届监事会第四次 会议的会议通知于 2025 年 4 月 8 日以电子通讯方式发出，并于 2025 年 4 月 18 日在公司会议室以现场表决的方式召开。本次监事会会议由监事会主席葛雅政先 生召集并主持，本次会议应到监事 3 人，实到监事 3 人。本次会议的召开符合 《公司法》等相关法律法规和《公司章程》的规定。 二、监事会会议审议情况 （一）审议通过《2024 年度监事会工作报告》 具体内容详见同日披露于巨潮资讯网（www.cninfo.com.cn）的《2024 年度监 事会工作报告》。 表决结果为：同意 3 票，反对 0 票，弃权 0 票。 本议案尚需提交公司 2024 年年度股东大会审议。 （二）审议通过《2024 年年度报告及其摘要》 经审议，监事会认为 ...

本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 证券代码:300692 证券简称:中环环保 公告编号:2025-008 债券代码:123146 债券简称:中环转 2 安徽中环环保科技股份有限公司 第四届董事会第六次会议决议公告 一、董事会会议召开情况 安徽中环环保科技股份有限公司（以下简称"公司"）第四届董事会第六次 会议的会议通知于 2025 年 4 月 8 日以电子通讯方式发出，并于 2025 年 4 月 18 日以现场表决与通讯表决相结合的方式召开。本次会议由董事宋永莲女士主持， 会议应到董事 9 人，实到董事 8 人，其中张伯中先生因公未能现场出席，以书面 形式委托董事程华女士代为出席会议并表决，甘复兴先生以通讯方式参加会议并 表决。公司监事和高级管理人员列席了本次会议。本次会议的召开符合《公司法》 等相关法律法规和《公司章程》的规定。 二、董事会会议审议情况 （一）审议通过《2024 年度董事会工作报告》 《2024 年度董事会工作报告》内容详见公司《2024 年年度报告》第三节"管 理层讨论与分析"部分及第四节"公司治理"部分相关内容。 公司 20 ...

安徽中环环保科技股份有限公司 第四届董事会独立董事第一次专门会议决议 2025 年 4 月 8 日，安徽中环环保科技股份有限公司（以下简称"公司"） 在公司会议室以现场和通讯相结合的方式召开第四届董事会独立董事第一次专 门会议，本次会议应到独立董事 3 人，实际出席独立董事 3 人，符合法定要求。 本次会议由独立董事姚云霞女士主持，经与会独立董事认真审议并投票表决，通 过如下决议： 一、审议通过《2024 年度利润分配预案》 二、审议通过《关于 2025 年度日常关联交易预计的议案》 经审核，公司预计与关联方发生的关联交易均为公司日常经营活动所需，是 基于公司正常的生产经营而进行的。本次关联交易定价遵循公平、公正、公开的 原则，均以市场价格为依据确定，不存在损害公司和全体股东特别是中小股东利 益的情形。本次关联交易不会影响公司正常的生产经营活动及独立性，不存在因 关联交易而在业务上对关联方形成依赖的情形。我们一致同意将此议案提交公司 董事会和股东大会审议，关联董事、与该关联交易有利害关系的关联股东需回避 表决。 表决结果为：同意 3 票，反对 0 票，弃权 0 票。 三、审议通过《关于公司及子公司接受大股东借 ...

Financial Performance - The company's operating revenue for 2024 reached ¥957,462,127.20, representing a 17.60% increase compared to ¥814,138,656.40 in 2023[22]. - Net profit attributable to shareholders decreased by 45.10% to ¥59,266,865.77 in 2024 from ¥107,962,308.38 in 2023[22]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥55,292,576.73, down 38.82% from ¥90,375,272.89 in 2023[22]. - Cash flow from operating activities significantly increased by 121.62% to ¥180,084,671.00 in 2024, compared to ¥81,258,198.27 in 2023[22]. - Basic earnings per share decreased by 44.11% to ¥0.1424 in 2024 from ¥0.2548 in 2023[22]. - Total assets at the end of 2024 were ¥6,856,894,314.66, a 3.37% increase from ¥6,633,628,145.75 at the end of 2023[22]. - The company's net assets attributable to shareholders increased slightly by 0.53% to ¥2,262,695,042.74 at the end of 2024 from ¥2,250,657,672.73 at the end of 2023[22]. - The company achieved operating revenue of 957.46 million yuan in 2024, representing a year-on-year growth of 17.6%[64]. - The net profit attributable to shareholders decreased by 45.1% to 59.27 million yuan, primarily due to increased bad debt provisions amounting to 59.18 million yuan[64]. - The cash flow from operating activities increased by 121.62% to 180.08 million yuan[64]. Dividend Distribution - The company plans to distribute a cash dividend of 0.3 RMB per 10 shares (including tax) based on a total share capital of 424,496,099 shares as of December 31, 2024, after deducting 9,560,890 shares in the repurchase account[6]. - The company plans to distribute cash dividends amounting to CNY 12,448,056.27, which is 100% of the total profit distribution amount[176]. - The cash dividend per 10 shares is CNY 0.30 (including tax), based on a total share base of 414,935,209 shares[177]. - The company has a policy to distribute at least 10% of the annual distributable profit as cash dividends, depending on profitability and cash flow[176]. - The company has not proposed any cash dividend distribution plan despite having positive distributable profits[178]. Risk Management - The company has outlined potential risks and countermeasures in the section discussing future development prospects in the management discussion and analysis[6]. - The company acknowledges potential risks from investment projects and the impact of changing national policies on project timelines and returns[125]. - The company is focused on maintaining safety and environmental compliance as core operational priorities[121]. - The company will focus on improving fund and cost management, internal controls, and cash flow management to mitigate risks associated with rapid growth[128]. Environmental Governance and Innovation - The company is positioned as a leader in comprehensive environmental governance solutions in China, focusing on water environment governance and solid waste resource utilization[50]. - The company is actively involved in the investment, construction, and operation of wastewater treatment and solid waste resource projects through various models such as BOT, BOO, and PPP[48]. - The company is expanding its renewable energy business by installing distributed photovoltaic systems at wastewater treatment and waste incineration plants, which reduces operational costs and increases energy self-sufficiency[52]. - The company is committed to providing one-stop services and comprehensive solutions in environmental governance, with a focus on innovation and efficiency in various sub-sectors[50]. - The company has applied for a total of 172 patents and software copyrights, with 99 patents and 17 software copyrights granted, establishing a technology system with independent intellectual property rights[49]. - The company is focusing on reducing investment in heavy asset projects while maintaining steady growth in its core businesses of water and solid waste management[64]. Corporate Governance - The company has established a governance structure that ensures equal rights for all shareholders, particularly minority shareholders, in decision-making processes[133]. - The board of directors consists of 9 members, including 3 independent directors, and operates under various specialized committees to ensure compliance and effective governance[134]. - The company maintains complete independence from its controlling shareholder in terms of assets, personnel, finance, and operations, ensuring a fully independent business model[136]. - The company has a dedicated financial management center with a standardized financial accounting system, allowing for independent financial decision-making[137]. - The company emphasizes the importance of governance and oversight through its supervisory board, which includes experienced professionals[150]. Research and Development - The company has established long-term partnerships with renowned universities for R&D, enhancing its technological capabilities and innovation[60]. - The company aims to develop a rapid and cost-effective antibiotic resistance gene detection method, with a projected sales revenue increase of at least 5 million and a profit increase of over 900,000[85]. - The company is committed to increasing R&D investment by at least 1 million, supporting its long-term growth strategy[85]. - The R&D team plans to apply for 2 patents and publish 1-2 papers as part of its ongoing research initiatives[89]. - The number of R&D personnel increased to 96, a rise of 39.13% from 69 in the previous year, with a notable increase in the proportion of undergraduate staff[90]. Employee Management - The total number of employees at the end of the reporting period was 1,006, with 876 in major subsidiaries[166]. - The company has a total of 1,278 employees receiving salaries during the reporting period[166]. - The professional composition includes 536 production personnel, 16 sales personnel, 335 technical personnel, 60 financial personnel, and 59 administrative personnel[166]. - The educational background of employees shows 2 with a doctorate, 34 with a master's degree, 234 with a bachelor's degree, and 736 with an associate degree or below[166]. - The company emphasizes a performance-based compensation policy linked to strategic goals, ensuring fairness and competitiveness[167]. Financial Management - The company has implemented cost-reduction measures and efficiency improvements across its projects, maintaining stable operational performance despite market challenges[65]. - The company successfully optimized its debt structure, taking advantage of lower loan rates to replace higher-rate project loans, significantly reducing financing costs[71]. - The company reported accounts receivable balances of 1,128.12 million, 856.52 million, and 569.08 million for the years ending 2024, 2023, and 2022 respectively, indicating a significant increase in receivables[124]. - The company intends to leverage government policies to recover overdue payments, with a focus on improving cash flow and profitability[119]. Market Trends and Opportunities - The water environment governance industry is experiencing growth due to increased national focus on water quality and infrastructure improvements[31]. - The total sewage treatment capacity in China reached 226 million tons per day in 2023, indicating a robust growth trajectory in the urban sewage treatment sector[31]. - The investment in urban sewage treatment and its reuse reached CNY 75.81 billion in 2023, while investment in county-level sewage treatment was CNY 31.12 billion, indicating a robust development trend in the sewage treatment industry[41]. - The overall market for industrial wastewater treatment is projected to expand further with the advancement of industrial park construction and policy guidance[33]. - The industrial wastewater treatment market is expected to grow, with a target of achieving a 94% reuse rate for industrial water by 2025[44]. Compliance and Reporting - The company emphasizes the importance of adhering to the disclosure requirements for energy-saving and environmental protection services as outlined in the Shenzhen Stock Exchange's self-regulatory guidelines[6]. - The company has not faced any penalties for environmental pollution during the reporting period, indicating compliance with environmental regulations[189]. - The company is committed to transparency in its ESG reporting, as highlighted in the 2023 ESG report[162]. - The internal control audit report received a standard unqualified opinion from the auditing firm[200].

Revenue and Profit - Revenue for Q1 2025 was CNY 194,834,994.74, a decrease of 11.59% compared to CNY 220,376,659.97 in the same period last year[4] - Net profit attributable to shareholders was CNY 20,671,530.39, down 35.43% from CNY 32,015,750.41 year-on-year[4] - Net profit excluding non-recurring items was CNY 19,143,599.37, a decline of 39.73% compared to CNY 31,764,116.96 in the previous year[4] - Total operating revenue decreased to ¥194,834,994.74 from ¥220,376,659.97, representing a decline of approximately 11.5% year-over-year[18] - Net profit for the period was ¥22,023,239.33, down from ¥33,513,581.01, indicating a decline of approximately 34.3% year-over-year[19] - The total comprehensive income for the period was CNY 22,023,239.33, compared to CNY 33,513,581.01 in the previous period, reflecting a decrease of approximately 34%[20] - The company reported a decrease in the total comprehensive income attributable to the parent company to CNY 20,671,530.39 from CNY 32,015,750.41, a decline of approximately 35.5%[20] Cash Flow and Assets - Operating cash flow increased significantly by 87.58%, reaching CNY 40,753,950.97, compared to CNY 21,726,421.60 in the same period last year[4] - Net cash flow from operating activities increased by 87.58% to $40.75 million in Q1 2025, up from $21.73 million in Q1 2024[10] - Cash and cash equivalents decreased by 31.37% to CNY 162,101,605.87, primarily due to increased payments during the period[9] - Cash and cash equivalents at the end of the period amount to ¥162,101,605.87, down from ¥236,211,335.75 at the beginning of the period[15] - The net cash flow from operating activities was CNY 40,753,950.97, an increase of 87.5% from CNY 21,726,421.60 in the previous period[23] - Cash and cash equivalents at the end of the period decreased to CNY 149,526,322.10 from CNY 555,899,178.47, a decline of approximately 73%[24] Liabilities and Equity - Total assets at the end of Q1 2025 were CNY 6,773,895,100.69, a decrease of 1.21% from CNY 6,856,894,314.66 at the end of the previous year[4] - Total liabilities decreased to ¥4,272,826,626.47 from ¥4,378,106,354.00, indicating a decline of approximately 2.4%[17] - Shareholders' equity attributable to the parent company increased by 0.92% to CNY 2,283,623,847.36 from CNY 2,262,695,042.74 at the end of the previous year[4] - The company's equity increased to ¥2,501,068,474.22 from ¥2,478,787,960.66, reflecting a growth of about 0.9%[17] Expenses and Costs - Operating costs decreased by 12.23% to $111.82 million in Q1 2025 from $127.41 million in Q1 2024[10] - Total operating costs decreased to ¥165,183,595.12 from ¥184,257,229.33, a reduction of about 10.4% year-over-year[19] - Research and development expenses increased by 14.20% to $3.38 million in Q1 2025 from $2.96 million in Q1 2024[10] - Research and development expenses increased to ¥3,381,386.82 from ¥2,961,004.60, representing a rise of approximately 14.2% year-over-year[19] Shareholder Information - The total number of common shareholders at the end of the reporting period is 19,125[12] - The largest shareholder, Zhang Bozhong, holds 15.45% of shares, totaling 65,565,434 shares[12] - The second-largest shareholder, Anhui Zhongchen Investment Holdings Co., Ltd., holds 12.76% of shares, totaling 54,150,000 shares[12] - The company has a repurchase account holding 9,560,890 shares, representing 2.25% of total shares[13] Other Financial Metrics - The company reported non-recurring gains of CNY 1,527,931.02, after accounting for tax effects and minority interests[7] - The company experienced a 57.35% reduction in income tax expenses, totaling $2.20 million in Q1 2025 compared to $5.15 million in Q1 2024[10] - Contract liabilities surged by 125.18% to $6.35 million, primarily due to hazardous waste not yet disposed of[10] - The company reported a credit impairment loss of ¥-8,509,051.47 compared to a gain of ¥981,747.07 in the previous period[19]

证券代码:300692 证券简称:中环环保 公告编号:2025-014 债券代码:123146 债券简称:中环转 2 安徽中环环保科技股份有限公司 关于 2024 年度利润分配预案的公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假 记载、误导性陈述或者重大遗漏。 2、审计委员会意见 特别提示： 1、安徽中环环保科技股份有限公司（以下简称"公司"）2024 年度利润分 配预案为：拟以 2024 年 12 月 31 日的公司总股本 424,496,099 股扣除公司回购专 用账户中的 9,560,890 股后的 414,935,209 股为基数，向全体股东每 10 股派发现 金红利 0.30 元（含税），合计派发现金红利人民币 12,448,056.27 元（含税）， 剩余未分配利润结转以后年度。本年度不送红股，不以公积金转增股本。 2、公司现金分红方案不涉及《深圳证券交易所创业板股票上市规则》第 9.4 条相关规定的可能被实施其他风险警示情形。 一、审议程序 公司于 2025 年 4 月 8 日召开第四届独立董事第一次专门会议及第四届董事 会审计委员会第四次会议，于 2025 年 4 月 ...

中环环保（300692）公告，2025年第一季度营业收入1.95亿元，同比下降11.59%。净利润2067.15万 元，同比下降35.43%。 ...

证券代码:300692 证券简称:中环环保 公告编号:2025-007 债券代码:123146 债券简称:中环转 2 安徽中环环保科技股份有限公司 关于特定股东减持计划的预披露公告 本公司特定股东金通安益保证向本公司提供的信息内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 特别提示： 本公司特定股东安徽高新金通安益股权投资基金（有限合伙）（以下简称"金 通安益"）计划在公告之日起 3 个交易日后 3 个月内（即 2025 年 4 月 25 日至 2025 年 7 月 24 日）通过集中竞价、大宗交易、协议转让方式合计减持公司股份 不超过 15,058,300 股（即不超过公司总股本的 3.55%，剔除公司回购专用账户中 的股份数量后，不超过公司总股本的 3.63%）。 安徽中环环保科技股份有限公司（以下简称"公司"）于近日收到特定股东 金通安益出具的《减持计划告知函》。现将有关情况公告如下： （一）股份减持计划 1、减持目的：资金需求，且本企业经营期限即将到期（从 2015 年 3 月 23 日至 2026 年 3 月 22 日 ...

| 证券代码:300692 | 证券简称:中环环保 | 公告编号:2025-006 | | --- | --- | --- | | 债券代码:123146 | 债券简称:中环转 2 | | 安徽中环环保科技股份有限公司 关于 2025 年第一季度可转换公司债券转股情况的公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假 记载、误导性陈述或者重大遗漏。 特别提示： 1、"中环转 2"（债券代码：123146）转股期为 2022 年 11 月 14 日至 2028 年 5 月 5 日，最新转股价格为 6.26 元/股。 2、2025 年第一季度，共有 723 张"中环转 2"完成转股（票面金额共计 72,300 元人民币），合计转成 11,549 股"中环环保"股票（股票代码：300692）。 3、截至 2025 年第一季度末，公司剩余可转换公司债券为 8,592,547 张，剩 余票面总金额为 859,254,700 元人民币。 根据《深圳证券交易所创业板股票上市规则》《深圳证券交易所上市公司自 律监管指引第 15 号——可转换公司债券》的有关规定，安徽中环环保科技股份 有限公司（以下简称 ...